.

Gilead Analysis Shows Remdesivir Reduced Coronavirus Death Risk

Gilead Sciences Inc said on Friday an analysis showed its antiviral remdesivir helped reduce the risk of death in severely ill COVID-19 patients, but cautioned that rigorous clinical trials were...

from NDTV News - World-news https://ift.tt/2Zh3nZ8

Resent New

Discord abandons Microsoft acquisition talks: Report

Discussion platform Discord, popular among amateur video game players, has halted acquisition talks with Microsoft and is instead considerin...

Most popular News